Abstract
Background
Cell number in 3-day-old (D3) embryos influences pregnancy outcomes in patients undergoing cleavage-stage embryo transfer. However, the association between D3 cell number and pregnancy outcomes following 5-day-old (D5) vitrified–thawed single blastocyst transfer remains underexplored.
Methods
This retrospective cohort follow-up study included 2035 cycles of D5 vitrified–thawed single blastocyst transfer. Patients were divided into six groups according to D3 embryo cell number: ≤5, 6, 7, 8, 9, and ≥ 10. Live birth rate (LBR), clinical pregnancy rate, miscarriage rate, and neonatal outcomes were compared across the groups. Statistical analyses were conducted using a multivariate logistic regression model. Furthermore, mediation analysis was performed to explore the association between D3 embryo cell number and LBR.
Results
LBR markedly increased with the D3 embryo cell number (p < 0.001). Subgroup analysis of high- and low-quality blastocysts also revealed significant differences in LBR across the groups (p < 0.05). Conversely, the miscarriage rate markedly decreased as the D3 embryo cell number increased (p < 0.05). The D3 embryo cell number and perinatal outcomes did not show an association. Compared with the 8-cell group, the ≤ 5-cell group had significantly lower LBR [aOR: 0.681, 95% confidence intervals (CI): 0.468–0.991, p < 0.05], whereas the ≥ 10-cell group had a significantly higher LBR (aOR: 1.632, 95% CI: 1.214–2.159, p < 0.01). Mediation analysis revealed that D3 embryo cell number provides unique prognostic information for live birth outcomes beyond blastocyst quality metrics. Furthermore, the inclusion of D3 embryo cell number improved the predictive performance of the ROC model (ΔAUC = 0.012, 95% CI: 0.004–0.023, p = 0.007).
Conclusion
D3 embryo cell number is a valuable supplementary indicator for selecting D5 blastocysts in vitrified–thawed single blastocyst transfer cycles. Among blastocysts with comparable morphological quality, those derived from fast-cleaving D3 embryos were associated with a lower miscarriage rate and a higher likelihood of live birth, specifically when transferring lower-quality blastocysts.
Keywords: D3 embryo cell number, Blastocyst quality, Frozen embryo transfer, Single blastocyst transfer, Live birth rate
Background
The main objective of assisted reproductive technology (ART) is to select the best embryo with high development potential for achieving a single healthy live birth. With its development, selective single embryo transfer has been widely promoted to alleviate adverse health outcomes in mothers and neonates. Therefore, selecting the highest developmental competitive embryo for the transfer is crucial.
The Istanbul consensus recommends that the optimal developmental rate for a 3-day-old (D3) embryo is reaching the eight-cell cleavage-stage [1, 2]. Some studies have demonstrated that embryos with either lower or higher cell numbers have markedly reduced developmental potential, which can negatively affect the pregnancy rate [3–5].
Recent advancements in embryo culture media and the increased utilization of vitrification have shifted the preference of using cleavage-stage embryo transfer to using blastocyst stage embryo transfer in ART [6]. Single blastocyst stage embryo transfer is widely accepted as a more effective method than multiple cleavage-stage embryo transfer for reducing the rate of multiple pregnancies without compromising clinical pregnancy rates [7]. The blastocyst grading system proposed by Gardner DK et al. [8] is frequently used to select blastocysts for embryo transfer. Blastocysts with high inner cell mass (ICM) and trophectoderm (TE) grading are associated with higher euploidy and implantation rates than those with lower morphology scores [9].
The transfer effects of single blastocysts arising from cleavage-stage embryos with different cell numbers remain unclear. A small cell number in D3 embryos is associated with lower clinical pregnancy rates and live birth rate (LBR) [10]. However, information on clinical pregnancy rates and LBRs in the transfer of blastocysts arising from fast-developing embryos is limited. Kroener et al. [11] suggested that blastocysts derived from fast-developing embryos are associated with markedly higher aneuploidy rates than those derived from embryos with 6–9 cells. Previous studies have demonstrated that fast-developing D3 embryos have euploidy rates comparable to those of 8-cell embryos [12, 13] and that the LBR of blastocysts derived from fast-developing embryos is similar between the > 8- and 8-cell groups [10, 14]. Therefore, it is crucial to determine whether fast-developing D3 embryos are superior to 8-cell embryos in predicting pregnancy outcomes in blastocysts with similar morphological quality. This study aimed to investigate the impact of D3 embryo cell number on pregnancy outcomes in patients undergoing 5-day-old (D5) vitrified–thawed single blastocyst transfers.
Methods
Study design and patients
This retrospective study included all patients (n = 2035 cycles) who underwent D5 vitrified–thawed single blastocyst transfer from January 2015 to December 2022 at the Reproductive Medicine Center of Guangdong Provincial fertility Hospital. The patients were divided into six groups based on D3 embryo cell number: ≤5 (n = 190), 6 (n = 208), 7 (n = 396), 8 (n = 717), 9 (n = 196), and ≥ 10 cells (n = 328). The LBR, clinical pregnancy rate, miscarriage rate, and neonatal outcomes were compared across the groups. Only first-time single D5 vitrified–thawed blastocyst transfers were included to ensure cohort homogeneity, as 6-day-old (D6) blastocysts exhibit distinct developmental kinetics and clinical outcomes and may serve as a significant confounder. The remaining exclusion criteria were as follows: patients with < 5 oocytes obtained in fresh cycle and had no surplus embryos for the next transfer and patients with factors that can adversely affect implantation, including hydrosalpinx, endometrial polyps, intrauterine adhesion, adenomyosis, myomas (≥ 4 cm in diameter or the submucous type), and uterine abnormalities. Preimplantation genetic testing is not conducted at the center. Therefore, none of the included patients underwent preimplantation genetic testing.
Embryo culture and assessment
Controlled ovarian stimulation was conducted according to the center’s standard long and short antagonist protocols. Ovulation was induced by administering 250-µg recombinant human chorionic gonadotropin (hCG; Ovidrel, Merck Serono, Switzerland) when at least two or three dominant follicles had a ≥ 17-mm diameter. Oocytes were retrieved 34–36 h post-hCG injection under vaginal ultrasound guidance. Insemination/injection was performed 39–40 h post-hCG injection. Embryos were individually cultured in 30-µL G1 medium droplets (G1 PLUS, Vitrolife Sweden AB, Sweden) under mineral oil (Vitrolife Sweden AB, Sweden) and incubated at 37 °C in a 6% CO2 and 5% O2 environment. Fertilization was evaluated 16–18 h following insemination/injection, and embryo quality was assessed on D3 (67–69 h), D5, and D6. After the patients’ 1–2 high-quality embryos were frozen on D3, all supernumerary embryos were individually cultured in 30-µL G2 medium droplet (G2 PLUS; Vitrolife Sweden AB, Sweden) until D5 or D6.
D3 cleavage-stage embryos were graded according to blastomere symmetry, fragmentation percentage, and cell number. The assessment criteria were based on the Istanbul consensus [3]. The remaining embryos were cultured to the blastocyst stage after vitrification of 1–2 high-quality D3 embryos (≥ 7cells). The blastocyst stage was evaluated using the Gardner scoring system [9]. High-quality blastocysts were defined as blastocysts with stage 3 or higher blastocyst expansion and ICM as well as TE scores higher than grade B, whereas those graded lower than 3BB were defined as low-quality blastocysts. In this study, CC-graded blastocysts were excluded and destroyed. Blastocysts with better grades were prioritized for transfer, regardless of the D3 embryo cell number.
Blastocyst vitrification and thawing
Blastocoels were artificially shrunken using a laser pulse (RI Saturn Active Laser System, England) prior to vitrification. Vitrification and warming were performed following the instructions provided in Vit Kits (Kitazato Corporation, Japan). The selection of blastocysts for vitrification was based solely on D5 morphological assessment using the Gardner grading system. Blastocysts with the highest morphological grades were selected for vitrification. On the day of embryo transfer, D5 blastocysts with the highest grading scores were preferentially selected for thawing and subsequent transfer.
Endometrial preparation
Natural cycles were employed for patients with regular menstrual cycles, whereas artificial hormone replacement therapy or stimulated cycles were used for patients with irregular menstruation or those with a history of thin endometrium.
Pregnancy and perinatal outcomes
The primary outcome of the study was LBR, defined as the delivery of a living baby after 28 weeks of gestation. The secondary endpoints included the clinical pregnancy and miscarriage rates. Neonatal outcomes among singletons were also assessed, including gestational age, birth weight, very preterm birth (< 32 weeks of gestation), preterm birth (PTM; <37 weeks of gestation), very low birth weight (≤ 1,500 g at birth), low birth weight (LBW, ≤ 2,500 g at birth), and high birth weight (≥ 4,000 g at birth). Furthermore, congenital malformations were detected. Clinical pregnancy was defined as the presence of an intrauterine gestational sac with fetal cardiac activity on day 35 after frozen embryo transfer. Miscarriage was defined as clinical pregnancy loss before the 28th gestational week.
Statistical analysis
All statistical analyses were conducted using Statistical Package for the Social Sciences (version 23.0; IBM Corp., Armonk, NY, USA). Patients were divided into six groups according to D3 embryo cell number: ≤5, 6, 7, 8, 9, and ≥ 10. This grouping was based on well‑established biological developmental thresholds: 8 cells represent optimal embryonic development, 7–9 cells constitute the ideal developmental window, ≤ 5 cells denote developmental delay, and ≥ 10 cells suggest accelerated cleavage. Continuous variables were expressed as means ± standard deviations and compared via one-way analysis of variance. Categorical variables were expressed as numbers and percentages and compared using Pearson’s chi-squared test or Fisher’s exact test. As five pairwise comparisons were performed, the Bonferroni adjustment for multiple comparisons was applied, with the adjusted significance threshold set at p < 0.01 (0.05/5). This stricter threshold was used for comparisons between each cell number subgroup and the 8-cell reference group. Logistic regression analysis was conducted to explore the independent effects of the D3 embryo cell number on clinical outcomes after controlling for potential confounders. day 3 cell number, female’s age, infertility duration, infertility type (primary or secondary), body mass index, stimulation protocol, fertilization protocol, number of oocytes retrieved, frozen embryo transfer preparation, endometrial thickness, blastomere symmetry, D3 embryo fragmentation, and individual blastocyst grades (expansion stage, ICM, and TE) were used as independent variables, whereas the LBR was used as the dependent variable. Using the 8-cell embryo group as reference, the adjusted odd ratios (aORs) of live birth were calculated. The results were reported as aORs with 95% confidence intervals (CIs). Mediation analysis was conducted using D3 embryo cell number as the independent variable, blastocyst quality as the mediator, and live birth as the dependent variable. Two-tailed p-values < 0.05 were considered statistically significant.
Results
Comparison of general characteristics
The patients’ baseline demographics are presented in Table 1. Results indicated that the number of oocytes retrieved per cycle, fragmentation percentage of D3 embryo were significant difference among the groups (p < 0.05), whereas the number of oocytes retrieved was significantly lower in the ≤ 5-cell group (11.84 ± 5.31) than in the 8-cell group (14.71 ± 5.46). The fragmentation percentage < 10% in group with blastomere numbers ≥ 10 cell (62.8%) was significantly higher than in the group with 8 cells (41.1%) (p < 0.01). In fragmentation percentage > 25% groups, the results were exactly the opposite.
Table 1.
Demographic and treatment characteristics of patients who underwent single blastocyst transfers
| Variable | ≤ 5 cells (n = 190) |
6 cells (n = 208) |
7 cells (n = 396) |
8 cells (n = 717) |
9 cells (n = 196) |
≥ 10 cells (n = 328) |
p value |
|---|---|---|---|---|---|---|---|
| Maternal age at transfer (years) | 32.72 ± 4.65 | 32.35 ± 4.69 | 32.60 ± 4.08 | 32.02 ± 4.24 | 32.07 ± 4.30 | 32.03 ± 4.34 | 0.289 |
| Maternal age at oocyte retrieval (years) | 31.73 ± 4.66 | 31.36 ± 4.69 | 31.55 ± 4.08 | 31.03 ± 4.22 | 31.17 ± 4.29 | 31.19 ± 4.38 | 0.146 |
| Maternal BMI (kg/m2) | 21.31 ± 2.68 | 21.41 ± 3.24 | 21.12 ± 2.52 | 21.23 ± 2.86 | 21.31 ± 2.64 | 21.48 ± 3.18 | 0.635 |
| Infertility duration (years) | 5.11 ± 3.52 | 4.86 ± 3.36 | 4.97 ± 2.99 | 4.76 ± 3.01 | 4.71 ± 2.70 | 4.86 ± 3.00 | 0.704 |
| Basal FSH ((IU/L)) | 6.50 ± 1.87 | 6.34 ± 1.71 | 6.22 ± 1.60 | 6.30 ± 1.59 | 6.22 ± 1.70 | 6.24 ± 1.62 | 0.449 |
| Infertility type n (%) | |||||||
| Primary infertility | 128(67.4) | 128(61.5) | 232(58.6) | 445(62.1) | 121(61.7) | 196(59.8) | 0.454 |
| Secondary infertility | 62(32.6) | 80(38.5) | 164(41.4) | 272(37.9) | 75(38.3) | 132(40.2) | - |
| Causes of infertility n (%) | - | - | |||||
| Female | 49(25.8) | 69(33.2) | 122(30.8) | 249(34.7) | 59 (30.1) | 92 (28.0) | 0.122 |
| Male | 104(54.7) | 111(53.4) | 203 (51.3) | 370(51.6) | 102(52.0) | 186(56.7) | 0.677 |
| Mixed | 29(15.3) | 21(10.1) | 61 (15.4) | 74(10.3) | 27(13.8) | 40(12.0) | 0.111 |
| Unexplained | 8(4.2) | 7(3.4) | 10(2.5) | 24(3.3) | 8(4.1) | 10(3.0) | 0.890 |
| Fertilization methods, n (%) | - | - | |||||
| IVF | 158(83.2) | 171(82.2) | 335(84.6) | 620(86.5) | 168(85.7) | 266(81.1) | 0.277 |
| ICSI | 32(16.8) | 37(17.8) | 61(15.4) | 97(13.5) | 28(14.3) | 62(18.9) | |
| Stimulation protocol, n (%) | - | - | |||||
| Agonist | 133(70.0) | 151(72.6) | 281(71.0) | 512(71.4) | 138(70.4) | 231(70.4) | 0.992 |
| Antagonist | 57(30.0) | 57(27.4) | 115(29.0) | 205(28.6) | 58(29.6) | 97(29.6) | - |
| Number of oocytes retrieved, median | 11.84 ± 5.31 | 12.89 ± 4.97 | 14.50 ± 5.52 | 14.71 ± 5.46 | 14.10 ± 5.21 | 114.01 ± 5.12 | 0.000 |
| FET preparation, n (%) | |||||||
| Natural cycle | 27(14.2) | 34(16.3) | 64(16.2) | 116(16.2) | 29(14.8) | 51(15.5) | 0.984 |
| Hormonal replacement cycle | 149(78.4) | 160(76.9) | 308(77.8) | 568(79.2) | 160(81.6) | 264(80.5) | 0.819 |
| Mild stimulation cycle | 14(7.4) | 14(6.7) | 24(6.1) | 33(4.6) | 7(3.6) | 13(4.0) | 0.304 |
| Endometrium thickness on the day of embryo transfer (mm) | 10.75 ± 2.25 | 10.98 ± 2.26 | 10.62 ± 2.26 | 10.85 ± 2.36 | 10.97 ± 2.29 | 10.77 ± 2.11 | 0.404 |
| Embryo parameters | |||||||
|
Blastomere symmetry, n (%) | |||||||
| Even | 64(33.7) | 67(32.2) | 113(28.5) | 244(34.0) | 60(30.6) | 94 (28.7) | 0.358 |
| Uneven | 126(66.3) | 141(67.8) | 283(71.5) | 473(66.0) | 136(69.4) | 234(71.3) | - |
|
Fragmentation percentage, n (%) | |||||||
| < 10% | 60(31.6) | 68(32.7) | 112(28.3) | 295(41.1) | 90(45.9) | 206(62.8) | 0.000 |
| 10%–25% | 77(40.5) | 68(32.7) | 196(49.5) | 348(48.5) | 86(43.9) | 103(31.4) | 0.000 |
| > 25% | 53(27.9) | 72 (34.6) | 88(22.2) | 74(10.3) | 20(10.2) | 19(5.8) | 0.000 |
Developmental potential of D3 embryo with different cell number by extended culture
A total of 14,370 embryos from 2035 cycles were included in the analysis, and the results indicated significant differences in the three key blastocyst developmental indicators across the groups. The blastocyst formation rate and available blastocyst rate increased with increasing cell number until reaching the 8-cell group, and then decreased in the 9-cell and ≥ 10-cell groups compared with the 8-cell group (p < 0.001). The high-quality blastocyst rate also exhibited an increasing trend with increasing cell number (p < 0.001). Furthermore, pairwise comparisons between each group and the 8-cell embryo group (used as the reference group) revealed significant differences in the rates of blastocyst formation, available blastocyst, and high-quality blastocyst (p < 0.01). Notably, multiple pairwise comparisons showed that the ≥ 10-cell group had a higher high-quality blastocyst rate than the 8-cell group (31.47% vs. 27.44%, p < 0.01; Fig. 1).
Fig. 1.

Developmental potential of D3 embryos with variable numbers of cell in extended culture (n = 14,370). According to Pearson’s X2 test, the formation rates of blastocyst, available blastocyst, and high-quality blastocyst were compared across the six groups, and the p-values for all the comparisons were all <0.001. For multiple pairwise comparisons, Bonferroni adjustment was applied, and a corrected *p < 0.01 was used as the significance threshold
Quality of D5 blastocyst developed from different day 3 embryo cell numbers
High- and low-quality blastocyst rates, as well as individual blastocyst grading parameters (ICM, TE, and expansion stage), were compared across the groups to evaluate the development potential of embryos with different cell numbers. The results indicated that all these comparison parameters exhibited significant differences across the groups (p < 0.001, Table 2). The proportions of high-quality blastocysts in the ≤ 5-, 6-, and 7-cell groups decreased compared with those in the 8-cell group (p < 0.01); however, they did not reveal any statistically significant differences among the 8-, 9-, and ≥ 10-cell groups (p ≥ 0.01). Furthermore, with the increase in the D3 embryo cell number, the proportion of the expansion stage of 3 were decreased and stage of 4 were increased, in ≥ 10 cell group the proportion was significantly differences compared with 8 cells group(p < 0.001). As the D3 embryo cell numbers increased, the proportion of grade A ICMes and grade A trophoblasts also significantly increased (p < 0.001).
Table 2.
Quality of transferred blastocysts developed from D3 embryos with different cell number
| ≤ 5 cells (n = 190) |
6 cells (n = 208) |
7 cells (n = 396) |
8 cells (n = 717) |
9 cells (n = 196) |
≥ 10 cells (n = 328) |
p value | |
|---|---|---|---|---|---|---|---|
| Blastocyst quality, n (%) | |||||||
| High-quality | 56 (29.5)* | 101(48.6)* | 217(54.8)* | 467(65.1) | 116(59.2) | 236 (72.0) | 0.000 |
| Low-quality | 134(70.5)* | 107(51.4)* | 179(45.2)* | 250(34.9) | 80(40.8) | 92(28.0) | 0.000 |
| Expansion, n (%) | 0.000 | ||||||
| 3 | 95(50.0)* | 49(23.6) | 101(25.5) | 141(19.7) | 31(15.8) | 26(7.9)* | 0.000 |
| 4 | 95(50.0)* | 156(75.0) | 285 (72.0) | 560(78.1) | 161(82.1) | 287(87.5)* | 0.000 |
| 5 | 0(0.0) | 3(1.4) | 10(2.5) | 16(2.2) | 4(2.0) | 15(4.6) | 0.028 |
| Inner cell mass, n (%) | 0.000 | ||||||
| A | 5(2.6) | 2(1.0)* | 13(3.3) | 56(7.8) | 12(6.1) | 41(12.5) | 0.000 |
| B | 133(70.0) | 154(74.0) | 317(80.1) | 565(78.8) | 147(75.0) | 245(74.7) | 0.053 |
| C | 52(27.4)* | 52(25.0)* | 66(16.7) | 96(13.4) | 37(18.9) | 42(12.8) | 0.000 |
| Trophectoderm, n (%) | 0.000 | ||||||
| A | 1(0.5) | 4(1.9) | 8 (2.0) | 32(4.5) | 6(3.1) | 24(7.3) | 0.000 |
| B | 105(55.3)* | 149(71.6) | 275 (69.4) | 531(74.1) | 147(75.0) | 253(77.1) | 0.000 |
| C | 84(44.2)* | 55(26.4) | 113(28.5) | 154(21.5) | 43(21.9) | 51(16.5) | 0.000 |
Data are expressed as number (percentage). A p value < 0.05 was considered statistically significant for all analyses. For multiple pairwise comparisons, Bonferroni adjustment was applied, and a corrected *p < 0.01 was adopted as the significance threshold
Pregnancy outcomes of vitrified–thawed single blastocyst transfer with different D3 embryo cell numbers
The association between clinical outcomes and D3 embryo cell number is presented in Table 3. LBRs were 28.4%, 34.6%, 42.9%, 44.6%, 45.9%, and 57.0% for the ≤ 5-, 6-, 7-, 8-, 9-, and ≥ 10-cell groups, respectively. LBR significantly increased between the groups (p < 0.001). Likewise, the clinical pregnancy rate and miscarriage rate markedly varied according to D3 embryo cell number (p < 0.01). The clinical pregnancy rate increased with the D3 embryo cell number (p < 0.001). However, the miscarriage rate decreased with the increase in D3 embryo cell number (p < 0.01). The clinical pregnancy rate and LBR in the ≥ 10-cell group significantly increased compared with the 8-cell group (p < 0.01); however, they significantly decreased in the ≤ 5-cell group (p < 0.01). Nonetheless, no differences were observed in preterm deliveries, very preterm deliveries, birth weight of newborns, or congenital malformations in perinatal outcomes (p > 0.05).
Table 3.
Pregnancy outcomes of vitrified–thawed single blastocyst transfer with different D3 embryo cell numbers
| ≤ 5 cells (n = 190) |
6 cells (n = 208) |
7 cells (n = 396) |
8 cells (n = 717) |
9 cells (n = 196) |
≥ 10 cells (n = 328) |
p value | |
|---|---|---|---|---|---|---|---|
| Clinical pregnancy, n (%) | 72(37.9)* | 102(49.0) | 193(48.7) | 389(54.3) | 105(53.6) | 207(63.1)* | 0.000 |
| Miscarriage, n (%) | 16(22.2) | 24(23.8) | 23(11.9) | 64(16.5) | 12(11.4) | 19(9.2) | 0.003 |
| Live birth, n (%) | 54(28.4)* | 72(34.6) | 170(42.9) | 320(44.6) | 90(45.9) | 187(57.0)* | 0.000 |
|
Preterm deliveries (< 37 weeks) |
1/54(1.9) | 4/72(5.6) | 6/ 170(3.5) | 10/320(3.1) | 4/90(4.4) | 1/187(0.5) | 0.239 |
| Very preterm deliveries (< 32 weeks) | 0/54(0.0) | 1/72 (1.4) | 3/170(1.8) | 6/320(1.9) | 1/90(1.1) | 0/187 (0.0) | 0.478 |
| Birth weight |
3330.93 (3219.74,3442.11) |
3177.08 (3072.81,3281.36) |
3347.82 (3274.56,3421.09) |
3273.55 (3219.98,3327.12) |
3220.78 (3116.13,3325.42) |
3447.25 (3112.28,3782.21) |
0.452 |
| < 1,500 g | 0/54(0.0) | 0/72(0.0) | 1/170(0.6) | 2/320(0.6) | 1/90(1.1) | 0/187(0.0) | 0.762 |
| < 2,500 g | 1/54(1.8) | 2/72(2.8) | 6/170(3.5) | 10/320(3.1) | 3/90(3.3) | 2/187(1.1) | 0.722 |
| > 4,000 g | 3/54(5.6) | 3/72 (4.1) | 14/170(8.2) | 17/320(5.3) | 3/90(3.3) | 10/187(5.3) | 0.430 |
| Genetic disorder/malformations, n (%) | 1/72(1.4) | 2/102(2.0) | 1/193(0.5) | 5/389(1.3) | 1/105(1.0) | 1/207(0.5) | 0.804 |
Data are expressed as number (percentage). A p value < 0.05 was defined as statistically significant for all analyses. For multiple pairwise comparisons, Bonferroni adjustment was applied, and a corrected *p < 0.01 was adopted as the significance threshold
Pregnancy outcomes of high- and low-quality blastocyst FET cycles
As shown in Table 4, in the high-quality blastocyst FET groups, the clinical pregnancy rate and LBR significantly differed across the groups (p < 0.05); however, the LBR was higher in the 10-cell than in the 8-cell group after Bonferroni adjustment (p < 0.01). No differences were observed in the miscarriage and congenital malformation rates across the six groups (p > 0.05). In the low-quality blastocyst FET group, the clinical pregnancy rate did not differ across the groups. However, the LBR and miscarriage rate significantly differed among them (p < 0.05). Miscarriage rates were 28.6%, 34.2%, 20.5%, 20.2%, 8.1%, and 6.5% in the ≤ 5-cell, 6-cell, 7-cell, 8-cell, 9-cell, and ≥ 10-cell groups, respectively, showing a significant decreasing trend (p < 0.01). However, the LBR increased with the D3 embryo cell number (p < 0.001).
Table 4.
Pregnancy outcomes of D5 high- and low-quality blastocyst frozen embryo transfer cycles
| ≤ 5 cells | 6 cells | 7 cells | 8 cells | 9 cells | ≥ 10 cells | p value | |
|---|---|---|---|---|---|---|---|
| High-quality blastocysts | 56 | 101 | 217 | 467 | 116 | 236 | |
| Clinical pregnancy, n (%) | 23(41.1)* | 63(62.4) | 121(55.8) | 279(59.7) | 68 (58.6) | 161(68.2) | 0.005 |
| Miscarriage, n (%) | 2(8.7) | 11(17.5) | 8((6.6) | 42(15.1) | 9(13.2) | 16(9.9) | 0.140 |
| Live birth, n (%) | 21(37.5) | 50(49.5) | 113(52.1) | 234(50.1) | 57(49.1) | 144(61.0)* | 0.018 |
| Genetic disorder/malformations, n (%) | 0(0.0) | 1(1.6) | 0(0.0) | 4(1.4) | 0(0.0) | 1(0.6) | 0.623 |
| Low-quality blastocysts | 134 | 107 | 179 | 250 | 80 | 92 | |
| Clinical pregnancy, n (%) | 49(36.6) | 39(36.4) | 72(40.2) | 110(44.0) | 37(46.3) | 46(50.0) | 0.250 |
| Miscarriage, n (%) | 14(28.6) | 13(34.2) | 15(20.5) | 22(20.2) | 3(8.1) | 3(6.5) | 0.008 |
| Live birth, n (%) | 33(24.6) | 22(20.6)* | 57(31.8) | 86(34.4) | 33(41.3) | 43(46.7) | 0.000 |
| Genetic disorder/malformations, n (%) | 1(2.0) | 1(2.6) | 1(1.4) | 1(0.9) | 1(2.7) | 0(0.0) | 0.875 |
Data are expressed as number (percentage). A p value < 0.05 was considered as statistically significant for all analyses. For multiple pairwise comparisons, Bonferroni adjustment was applied, and a corrected *p < 0.01 was used as the significance threshold
Results of logistic regression analysis and ROC curves of some variables on LBR
The results of the logistic regression analysis for LBR, adjusted for confounding variables, are presented in Table 5. The ≥ 10-cell group had higher LBR than the 8-cell group (aOR 1.632, 95% CI: 1.214–2.159, p = 0.001), Conversely, the likelihood of live birth was significantly lower in patients who underwent transfers with ≤ 5-cell embryos (aOR 0.681, 95% CI: 0.468–0.991, p = 0.045). Moreover, female age, infertility duration, endometrial thickness, blastocyst expansion stage 4, ICM, and TE grade significantly influenced LBR.
Table 5.
Results of the logistic regression analysis of LBR
| OR | 95% CI | P value | |
|---|---|---|---|
| D3 embryo cell number | |||
| ≤ 5 cells | 0.681 | 0.468,0.991 | 0.045 |
| 6 cells | 0.729 | 0.518,1.024 | 0.068 |
| 7 cells | 1.051 | 0.810,1.362 | 0.709 |
| 8 cells | Reference | Reference | Reference |
| 9 cells | 1.120 | 0.806,1.557 | 0.499 |
| ≥ 10 cells | 1.632 | 1.214,2.159 | 0.001 |
| Maternal age at transfer (years) | 0.952 | 0.927,0.977 | 0.000 |
| Infertility duration (years) | 0.956 | 0.926,0.990 | 0.011 |
| Maternal BMI (kg/m2) | 1.008 | 0.975,1.042 | 0.633 |
| Fertilization protocol, n (%) | |||
| IVF | Reference | ||
| ICSI | 0.968 | 0.748,1.254 | 0.806 |
| Stimulation protocol, n (%) | |||
| Agonist | Reference | ||
| Antagonist | 1.047 | 0.850, 1.289 | 0.667 |
| Number of oocytes retrieved, median | 1.007 | 0.989,1.026 | 0.446 |
| FET preparation, n (%) | |||
| Natural cycle | Reference | ||
| Hormonal replacement cycle | 0.980 | 0.759,1.265 | 0.875 |
| Mild stimulation cycle | 1.048 | 0.646,1.701 | 0.849 |
| Endometrium thickness on the day of embryo transfer (mm) | 1.057 | 1.014,1.102 | 0.010 |
| Evenness of the cells of D3 embryos | |||
| Even | Reference | ||
| Uneven | 0.970 | 0.787,1.196 | 0.776 |
| Fragmentation of D3 embryos | |||
| 3 | Reference | ||
| 2 | 0.779 | 0.579,1.048 | 0.099 |
| 1 | 0.831 | 0.623,1.110 | 0.210 |
| Expansion | |||
| 3 | Reference | ||
| 4 | 1.372 | 1.081,1.743 | 0.009 |
| 5 | 0.804 | 0.418,1.546 | 0.513 |
| Inner cell mass | |||
| A | 3.923 | 2.477,6.215 | 0.000 |
| B | 2.647 | 1.992,3.518 | 0.000 |
| C | Reference | ||
| Trophectoderm | |||
| A | 1.380 | 0.820,2.321 | 0.225 |
| B | 1.604 | 1.269,2.028 | 0.000 |
| C | Reference | ||
The factors related to LBR obtained via logistic regression were included in the ROC. The AUC of the ROC improved after including D3 embryo cell number (Combation2-Combation1AUC = 0.012, 95% CI: 0.004–0.023, p = 0.007; Supplementary Fig. 2).
Mediating role of blastocyst quality on the association between D3 embryo cell number and live birth
Table 6 presents the direct and indirect effects of D3 embryo cell number on live birth, with blastocyst quality grade as the mediator. The results indicated that the direct effect of D3 embryo cell number on live birth was significant (β = 0.1192, p < 0.0001, 95% CI [0.0733, 0.1651]). The indirect effect mediated by blastocyst quality grade was significant (β = 0.0314, Boot 95% CI [0.0204, 0.0435], excluding zero). Blastocyst quality partially mediated the relationship between D3 embryo cell number and live birth, accounting for 20.85% of the total effect.
Table 6.
Mediating effects of blastocyst quality on association between D3 embryo cell number and live birth
| Path | Estimate (β) | 95% CI | Proportion of indirect effect |
|---|---|---|---|
| Direct effect (D3 embryo cell number → live birth) | 0.1192 | [0.0733, 0.1651] | - |
| Indirect effect via blastocyst quality (D3 embryo cell number → blastocyst quality → live birth) | 0.0314 | [0.0204, 0.0435] | 20.85% |
| Total effect | 0.1506 | - | 100% |
Discussion
The present study demonstrates that a higher D3 embryo cell number is positively correlated with LBR in cycles involving D5 vitrified–thawed single blastocyst transfer. In addition, the miscarriage rate following D5 vitrified–thawed single blastocyst transfer is markedly influenced by D3 embryo cell number, particularly when low-quality blastocysts are transferred. These findings suggest that D3 embryo cell number can serve as a valuable reference indicator for optimal blastocyst selection in clinical IVF practice.
At present, time-lapse microscopy technologies [15], preimplantation genetic testing [16], and culture media analysis [17] have been employed to assess embryo quality. Nevertheless, many laboratories do not have those technologies, and the familiar and reliable morphological scoring remains the most widely used criterion owing to its low cost and noninvasive nature [1]. Of all morphological characteristics typically evaluated in cleavage-stage (D3) embryos, the blastomere number is believed to be the single most important indicator of embryo viability [18]. Meanwhile, the most widely accepted morphological scoring criterion for D3 embryos is the Istanbul consensus, which claimed that an optimal D3 embryo would have eight equally sized blastomeres, whereas embryos cleaving slower or faster are likely to be abnormal [1, 2]. National data from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) also reported that LBR is positively associated with increased cell numbers up to 8 but was reduced in embryos with over 8 cells [19]. A low D3 embryo cell number usually indicates poor prognosis. Studies have confirmed that the transfer of slow-developing embryos results in low implantation rates and LBR [20, 21]. In this regard, several possible reasons have been proposed. First, slow-developing embryos have higher aneuploidy rates and reduced likelihood of releasing euploid blastocysts [11, 12]. Other reasons include fewer surviving blastomeres, which may lead to developmental arrest or unexplained delays [22]. Our findings are consistent with the general consensus regarding the reduced developmental potential of slow-developing embryos.
However, controversies regarding the developmental potential of fast-developing embryos have long persisted. They hypothesized that fast-cleaving embryos have similar or even higher developmental competence compared with 8-cell embryos [12, 20–25]. Luna et al. reported that fast-cleaving embryos (> 10 cells) not only reach the blastocyst stage at a similar rate to moderately cleaving embryos (8 cells) but also have a significantly higher likelihood of developing into higher-quality blastocysts [22]. Pons et al. reported that > 11-cell embryos can give rise to an euploid blastocyst as the 8-cell embryos, euploid blastocysts derived from > 11-cell embryos and from 8-cell embryos exhibit similar LBRs in preimplantation genetic testing [12]. Time-lapse culture combined with an AI scoring system is gradually being applied in embryo laboratories. Recent studies [24, 25] using iDAScore v2.0 for embryo ranking have reported that D3 embryos with > 8 cells consistently receive the highest morphological scores. Furthermore, the transfer of these embryos has been associated with significantly higher LBRs.
Extended culture allows for the selection of high-quality embryos while eliminating those with chromosomal abnormalities or poor developmental potential [26]. For blastocysts with similar morphological quality, does the cell number of D3 embryos influence their developmental potential? At present, there are few studies focusing on this topic, and their conclusions remain inconsistent, particularly regarding blastocysts arising from fast-developing D3 embryos. Wu et al. [10] analyzed the association between D3 embryo cell number and its pregnancy outcomes in vitrified–thawed single blastocyst transfer cycles and found that the clinical pregnancy and LBRs were similar between the > 8- and 8-cell groups. Nevertheless, other studies reported that the clinical pregnancy and LBR of blastocysts transferred in the > 8-cell group significantly increased compared with those of blastocysts transferred in the < 8- or 8-cell groups [27]. A time-lapse image research also indicated that a higher cell number was associated with a higher rate of blastocyst formation. The implantation rate and LBR increased from 36.4% (5–6 cells) to 62.5% (> 10 cells) and from 27.3% (5–6 cells) to 57.0% (> 10 cells) as the cell numbers increased in normal embryos [22]. The results of our study were to some extent consistent with the studies mentioned above, and the clinical outcomes significantly improved as the D3 embryo cell number increased. Specifically, the transfer of blastocysts derived from fast-developing embryos is associated with higher clinical pregnancy and LBRs. The reason why blastocysts arising from fast-developing D3 embryos are associated with higher LBR remains unclear. The developmental potential of D3 embryos was compared across different cell numbers using extended culture, revealing that blastocyst formation and available blastocyst rates increased in embryos with cell numbers of up to 8 but decreased in those with > 8 cells. However, the rate of high-quality blastocysts increased in the ≥ 10-cell group compared with that in the 8-cell group. These results suggest that 8-cell embryos have the greatest potential to develop into blastocysts; however, fast-developing embryos (≥ 10 cells) can form blastocysts with superior morphological quality in extended culture. Our data also indicate that fast-developing embryos (≥ 10 cells) are more likely to develop into high-quality blastocysts at stage 4. Our findings are consistent with those of other studies [22, 23]. Kong et al. [22] used a time-lapse imaging technology to monitor embryos and found that those with high cell numbers resulted from accelerated cell cycles, which were associated with a higher developmental potential.
Our study showed that as the cell number increased, the miscarriage rate markedly decreased, particularly in low-quality blastocysts (p = 0.008). The miscarriage rate was lower in the ≥ 10-cell than in the 8-cell group; however, the difference was not significant (p = 0.026). This trend could be attributed to the relatively small number of samples included in the ≥ 10-cell group. Larger-scale studies are warranted to confirm this finding. Several studies [14, 27] have reported that the miscarriage rates exhibited no statistically significant differences between the > 10- and 8-cell–derived blastocysts in the frozen embryo transfer group; however, comparable but lower miscarriage rates (4.3% vs. 13.5%; p = 0.04) were observed in the ≥ 10- and 8-cell groups during ET cycles [13]. Some studies have also reported that blastocysts arising from good-quality D3 embryos with high cell numbers are associated with lower miscarriage rates [28, 29]. These observations agree to some extent with the results of our study. As chromosomal abnormality is one of the main reasons for early spontaneous abortions [28], morphological evaluation alongside preimplantation genetic testing should be conducted to confirm our outcomes. Moreover, in this study, no association was observed between the number of D3 blastomeres and neonatal outcomes. This result is consistent with the findings of Chen L et al. [30]. However, Zhao et al. [14] found that blastocysts derived from fast-developing D3 embryos were associated with improved neonatal outcomes, including high mean birth weight, low rates of infants with LBW, and low rates of PTM. Further studies are warranted to determine whether the rapid developmental speed of fast-cleaving embryos influences neonatal outcomes.
According to the results of logistic regression analysis, the cell number of D3 embryos was an independent predictor of live birth after adjusting for other confounding factors. It is well recognized that D3 embryo cell number is a core indicator of early embryonic developmental potential and is closely related to subsequent blastocyst formation and quality. From a logical perspective, the predictive effect of D3 embryo cell number on live birth may be largely embedded within blastocyst quality, raising the concern that D3 embryo cell number may lack independent predictive value for live birth once blastocyst quality is considered.
However, the present mediation analysis confirmed that although D3 embryo cell number can positively influence live birth indirectly by enhancing blastocyst quality, it still exerted a significant direct predictive effect on live birth independent of blastocyst quality. These findings suggest that D3 embryo cell number is not merely a preliminary factor implicitly reflected in blastocyst quality; instead, it provides additional and independent prognostic value for live birth outcome beyond the predictive contribution of blastocyst quality alone.
This study has several inherent limitations that need to be acknowledged. First, it was conducted at a single reproductive center, and although all embryos were uniformly evaluated by two experienced embryologists to minimize interobserver variability, potential embryo selection bias cannot be completely ruled out. Second, embryologists and clinicians subjectively prioritized higher‑quality 8‑cell embryos for D3 cryopreservation, potentially introducing inevitable clinical decision bias. Third, although multivariate regression models were used to account for known confounders, the possibility of unmeasured or residual confounding—such as subtle differences in gamete quality or endometrial receptivity—cannot be ruled out. Fourth, given the nonrandomized observational design, formal causal inference is inappropriate; our findings only illustrate a correlative and predictive association rather than a direct causal relationship between D3 embryo cell number and live birth outcomes. This study also has several strengths. First, it used a relatively large data sample to demonstrate the association between LBRs and D3 embryo cell number in D5 vitrified–thawed single blastocyst transfer cycles. Second, multivariate regression models were developed to control for multiple confounding factors. Third, mediation effect analysis was further applied to systematically elucidate the direct and indirect pathways of D3 cell number that influence live birth.
Conclusion
Our study suggests that D3 embryo cell number serves as a valuable supplementary indicator for selecting D5 blastocysts in vitrified–thawed single blastocyst transfer cycles. For blastocysts with comparable morphological quality, those derived from fast-cleaving D3 embryos appeared to be associated with a lower miscarriage rate and a higher likelihood of live birth, particularly when transferring low-quality blastocysts. Further prospective studies with larger sample sizes are warranted to validate these findings.
Supplementary Information
Acknowledgements
We gratefully acknowledge the staff of the Reproductive Medicine Center in Guangdong Provincial Fertility Hospital for their support and cooperation.
Abbreviations
- LBR
Live birth rate
- ART
Assisted reproductive technology
- ICM
Inner cell mass
- TE
Trophectoderm
- BMI
Body mass index
- aOR
Adjusted odds ratio
- CIs
Confidence intervals
- hCG
Human chorionic gonadotropin
- VPTM
Very preterm birth
- PTM
Preterm birth
- VLBW
Very low birth weight
- LBW
Low birth weight
- HBW
High birth weight
- IVF
In vitro fertilization
Authors’ contributions
W.Z. supervised the entire study, including the procedures, conception, design, and completion. S.L. and Y.H. were responsible for data collection. L.H conducted the statistical analyses. Y.T.,C.M. and Y.C. performed embryo culture and transfer. R.J. and T.M. supervised the project administration. All authors approved the final manuscript after critical revisions for intellectual content.
Funding
This study was supported by grants from the Guangdong Provincial Medical Research Fund (A2020604).
Data availability
Data available on request from the corresponding author.
Declarations
Ethics approval and consent to participate
This study adhered to the Declaration of Helsinki and was conducted in accordance with the relevant local guidelines and regulations. The present study was approved by the ethics committee of Guangdong Provincial fertility Hospital, and all participants had signed the informed consent during treatment.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Supplementary Information
The online version contains supplementary material available at https://doi.org/10.1186/s12884-026-09868-7.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Working Group on the update of the ESHRE/ALPHA Istanbul Consensus, Coticchio G, Ahlström A, Arroyo G, Balaban B, Campbell A, De Los Santos MJ, et al. The Istanbul consensus update: a revised ESHRE/ALPHA consensus on oocyte and embryo static and dynamic morphological assessment. Hum Reprod. 2025;40:989–1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26:1270–83. [DOI] [PubMed] [Google Scholar]
- 3.Ziebe S, Petersen K, Lindenberg S, Andersen AG, Gabrielsen A, Andersen AN. Embryo morphology or cleavage stage: how to select the best embryos for transfer after in-vitro fertilization. Hum Reprod. 1997;12:1545–9. [DOI] [PubMed] [Google Scholar]
- 4.Alikani M, Calderon G, Tomkin G, Garrisi J, Kokot M, Cohen J. Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro. Hum Reprod. 2000;15:2634–43. [DOI] [PubMed] [Google Scholar]
- 5.Stylianou C, Critchlow D, Brison DR, Roberts SA. Embryo morphology as a predictor of IVF success: an evaluation of the proposed UK ACE grading scheme for cleavage stage embryos. Hum Fertil (Camb). 2012;15:11–7. [DOI] [PubMed] [Google Scholar]
- 6.Glujovsky D, Cornelisse S, Blake D, Quinteiro Retamar AM, Alvarez Sedo CR, Ciapponi A. Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev. 2022;5:CD002118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sundhararaj UM, Madne MV, Biliangady R, Gurunath S, Swamy AG, Gopal IST. Single blastocyst transfer: the key to reduce multiple pregnancy rates without compromising the live birth rate. J Hum Reprod Sci. 2017;10:201–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obstet Gynecol. 1999;11:307–11. [DOI] [PubMed] [Google Scholar]
- 9.Minasi MG, Colasante A, Riccio T, Ruberti A, Casciani V, Scarselli F, et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod. 2016;31:2245–54. [DOI] [PubMed] [Google Scholar]
- 10.Wu J, Zhang J, Kuang Y, Chen Q, Wang Y. The effect of day 3 cell number on pregnancy outcomes in vitrified-thawed single blastocyst transfer cycles. Hum Reprod. 2020;35:2478–87. [DOI] [PubMed] [Google Scholar]
- 11.Kroener LL, Ambartsumyan G, Pisarska MD, Briton-Jones C, Surrey M, Hill D. Increased blastomere number in cleavage-stage embryos is associated with higher aneuploidy. Fertil Steril. 2015;103:694–8. [DOI] [PubMed] [Google Scholar]
- 12.Pons MC, Carrasco B, Parriego M, Boada M, González-Foruria I, Garcia S, et al. Deconstructing the myth of poor prognosis for fast-cleaving embryos on day 3. Is it time to change the consensus? J Assist Reprod Genet. 2019;36:2299–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zhao H, Liu H, Li M, Ma S, Li C, Wu K. Over ten-cell good embryo transfers on day three have equivalent clinical outcomes with those of eight-cell embryos in female patients aged ≤ 35 years: a retrospective cohort study. Gynecol Obstet Invest. 2019;84:298–304. [DOI] [PubMed] [Google Scholar]
- 14.Zhao H, Liu H, Li M, Wu K. Clinical outcomes following frozen-thawed blastocyst transfers with blastocysts derived from different cell numbers on day 3: a retrospective cohort study. J Assist Reprod Genet. 2020;37:641–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Polanski LT, Coelho Neto MA, Nastri CO, Navarro PA, Ferriani RA, Raine-Fenning N, et al. Time-lapse embryo imaging for improving reproductive outcomes: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2014;44:394–401. [DOI] [PubMed] [Google Scholar]
- 16.Yang H, DeWan AT, Desai MM, Vermund SH. Preimplantation genetic testing for aneuploidy: challenges in clinical practice. Hum Genomics. 2022;16:69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zmuidinaite R, Sharara FI, Iles RK. Current advancements in noninvasive profiling of the embryo culture media secretome. Int J Mol Sci. 2021;22:2513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Machtinger R, Racowsky C. Morphological systems of human embryo assessment and clinical evidence. Reprod Biomed Online. 2013;26:210–21. [DOI] [PubMed] [Google Scholar]
- 19.Racowsky C, Stern JE, Gibbons WE, Behr B, Pomeroy KO, Biggers JD. National collection of embryo morphology data into Society for assisted reproductive technology clinic outcomes reporting system: associations among day 3 cell number, fragmentation and blastomere asymmetry, and live birth rate. Fertil Steril. 2011;95:1985–9. [DOI] [PubMed] [Google Scholar]
- 20.Tian L, Xia L, Liu H, Kou Y, Huang Z, Wu X, et al. Increased blastomere number is associated with higher live birth rate in day 3 embryo transfer. BMC Pregnancy Childbirth. 2022;22:198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Li B, Huang J, Li L, He X, Wang M, Zhang H, et al. Improving the clinical outcomes by extended culture of day 3 embryos with low blastomere number to blastocyst stage following frozen-thawed embryo transfer. Arch Gynecol Obstet. 2021;303:573–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kong X, Yang S, Gong F, Lu C, Zhang S, Lu G, et al. The relationship between cell number, division behavior and developmental poten tial of cleavage stage human embryos: a time-lapse study. PLoS ONE. 2016;11:e0153697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Luna M, Copperman AB, Duke M, Ezcurra D, Sandler B, Barritt J. Human blastocyst morphological quality is signifcantly improved in embryos classifed as fast on day 3 (> or = 10 cells), bringing into question current embryological dogma. Fertil Steril. 2008;89:358–63. [DOI] [PubMed] [Google Scholar]
- 24.Ahlström A, Berntsen J, Johansen M, Bergh C, Cimadomo D, Hardarson T, et al. Correlations between a deep learning-based algorithm for embryo evaluation with cleavage-stage cell numbers and fragmentation. Reprod Biomed Online. 2023;47:103408. [DOI] [PubMed] [Google Scholar]
- 25.Wang X, Wei Q, Huang W, Yin L, Ma T. Can time-lapse culture combined with artificial intelligence improve ongoing pregnancy rates in fresh transfer cycles of single cleavage stage embryos? Front Endocrinol (Lausanne). 2024;15:1449035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Majumdar G, Majumdar A, Verma IC, Upadhyaya KC. Relationship between morphology, euploidy and implantation potential of cleavage and blastocyst stage embryos. J Hum Reprod Sci. 2017;10:49–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wang J, Diao Z, Fang J, Zhu L, Xu Z, Lin F, et al. The influence of day 3 embryo cell number on the clinical pregnancy and live birth rates of day 5 single blastocyst transfer from frozen embryo transfer cycles. BMC Pregnancy Childbirth. 2022;22:980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Xia L, Zhao S, Xu H, Wu X, Zhang A, Niu Z. Miscarriage rate is high with frozen-thawed blastocysts arising from poor-quality cleavage stage embryos. Front Endocrinol (Lausanne). 2020;11:561085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Dai X, Gao T, Xia X, Cao F, Yu C, Li T, et al. Analysis of biochemical and clinical pregnancy loss between frozen-thawed embryo transfer of blastocysts and day 3 cleavage embryos in young women: a comprehensive comparison. Front Endocrinol (Lausanne). 2021;12:785658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Chen L, Wang J, Zhu L, Xu Z, Zhang N, Lin F, et al. The effect of the day 3 embryo cell number on the neonatal outcomes of day 5 single blastocyst transfer in frozen embryo transfer cycles. Eur J Obstet Gynecol Reprod Biol. 2023;283:81–5. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data available on request from the corresponding author.
